United States· US:0990-7935_6785bd83-c705-41a5-a19c-906f03f380e3
Dextrose
A glucose product containing dextrose, registered in United States by ICU Medical Inc.. The same ATC class is registered in 3 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Glucose is registered in 3 of 19 countries.
Countries holding a registration under ATC B05CX01 (glucose), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 2 of them publish a price we can compare per daily dose
Glucose · ATC B05CX01
3 / 19 countries
- Belgiumprice
- Japan
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- dextrose
- Manufacturer
- ICU Medical Inc.
- Country
- United States (US)
- ATC code
- B05CX01
- ATC class
- Glucose
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- June 3, 2026
Packs & prices · 1
- ndc11099079351912 POUCH in 1 CASE (0990-7935-19) / 1 BAG in 1 POUCH / 500 mL in 1 BAG
Regulatory notes
Interactions
1 interaction on record for glucose.
Graded by severity as the source publishes them — 1 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Glucose · interactions on record
1 record
- 1 moderate
Most severe, free to view
- Fludeoxyglucose (18F)V09IX04moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Glucose in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaGLUCOSE FRESENIUS KABI 20%Fresenius Kabi s.r.o., Praha
- FinlandGlucos B. BraunB. Braun Melsungen AG
- SwedenGlucos Fresenius Kabi 200 mg/ml Infusionsvätska, lösningFresenius Kabi AB
- BelgiumGlucose Sterop 200 mg/mlLaboratoires Sterop
- NorwayGlucos Fresenius KabiFresenius Kabi Norge AS
- PolandGlucosum 20% FreseniusFresenius Kabi Polska Sp. z o.o.
- IcelandGlucos Fresenius KabiFresenius Kabi AB
- United KingdomAACE Gluco 40% gelEssential-Healthcare Ltd
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Glucose B. Braun, Glucose Fresenius
- Belgium · Glucose Aguettant, Glucose B. Braun
- Bulgaria · Глюкоза Бакстер, Глюкоза Браун
- Cyprus · Dextrose /Demo 20%, Dextrose Demo
- Czechia · Ardeanutrisol G, Glucose Fresenius Kabi
- Germany · Glucose B. Braun, Glucose Laboratoire Aguettant
- Denmark · Glucos B. Braun, Glucos Fresenius Kabi
- Estonia · Glucose B. Braun, Glucose B.Braun
- Spain · Dextrosa Fresenius Kabi, Freeflex Glucosa
- Finland · Glucos B. Braun, Glucos Fresenius Kabi
- France · Glucose Aguettant, Glucose B. Braun
- United Kingdom (Northern Ireland) · Glucose Aguettant, Glucose B. Braun Melsungen
- Greece · Dextrose Cooper, Dextrose Fresenius
- Croatia · Glukoza B. Braun, Glukoza Fresenius Kabi
- Hungary · Glucose B. Braun, Glucosum Pannonpharma
- Ireland · Glucose, Glucose Baxter Holding
- Iceland · Glucos Fresenius Kabi, Glucos Viaflo Baxter
- Italy · Glucorange, Glucosio
- Lithuania · Glucose B. Braun, Glucose B.Braun
- Luxembourg · Glucose, Glucose B. Braun
- Latvia · Glucose B.Braun, Glucose Fresenius
- Malta · Dextrose Vioser, Glucose Baxter Holding
- Netherlands · Glucose, Glucose 5% G/V
- Norway · Glucos B. Braun, Glucos Fresenius Kabi
- Poland · Gluco Test, Glucosi Baxter
- Portugal · Glucosada, Glucosada Grifols
- Romania · Dextrose Vioser, Glucose B Braun
- Sweden · Glucos B. Braun, Glucos Fresenius Kabi
- Slovenia · Glukoza Baxter, Glukoza Braun
- Slovakia · Glucose Fresenius Kabi, Glucose Intravenous Infusion B.P. Bieffe
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bc62cb47-4ba7-4a78-8827-7d7a857a7d1f GET /v1/drugs/bc62cb47-4ba7-4a78-8827-7d7a857a7d1f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unii": {
"unii": "LX22YL083G",
"rxcui": "1299920",
"inchikey": "SPFMQWBKVUQXJV-BTVCFUMJSA-N",
"display_name": "DEXTROSE MONOHYDRATE",
"substance_type": "chemical",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "INTRAVENOUS",
"spl_meta": {
"60b6d7c3-0164-46c9-aa38-b5aa1c31a5d5": {
"match": "brand_token",
"title": "DEXTROSE INJECTION, SOLUTION [B. BRAUN MEDICAL INC.]",
"spl_version": "11",
"published_date": "2026-05-25"
}
},
"productid": "0990-7935_6785bd83-c705-41a5-a19c-906f03f380e3",
"productndc": "0990-7935",
"dosage_form": "INJECTION, SOLUTION",
"orange_book": {
"appl_no": "018564",
"products": [
{
"rs": true,
"rld": true,
"te_code": null,
"strength": "20GM/100ML",
"product_no": "001",
"approval_date": "Mar 23, 1982"
}
],
"appl_type": "N"
},
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "DEXTROSE MONOHYDRATE",
"shortage_reason": "Dextrose Monohydrate 50% Injection",
"shortage_status": "current",
"proprietary_name": "Dextrose",
"active_ingred_unit": "g/100mL",
"application_number": "NDA018564",
"marketing_category": "NDA",
"nonproprietary_name": "dextrose",
"start_marketing_date": "20191001",
"active_numerator_strength": "20"
}See everything about glucose.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.